1. Chui HC. Dementia due to subcortical ischemic vascular disease. Clin Cornerstone

2. Fein G, Di S, V, Tanabe J, et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease [In Process Citation]. Neurology 2000;55 (11):1626-35.

3. Mungas D, Jagust WJ, Reed BR, et al. MRI Predictors of Cognition in Subcortical

Ischemic Vascular Disease and Alzheimer's Disease. Neurology 2001;57(12):2229-35.

4. Du AT, Schuff N, Laakso MP, et al. Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus. Neurology 2002;58(11):1635-41.

5. Laakso MP, Partanen K, Riekkinen P, et al. Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study. Neurology 1996;46:678-81.

6. Baron JC, D'Antona R, Pantano P, Serdaru M, Samson Y, Bousser MG. Effects of thalamic stroke on energy metabolism of the cerebral cortex. A positron tomography study in man. Brain 1986;109 ( Pt 6):1243-59.

7. Kwan LT, Reed BR, Eberling JL, et al. Effects of subcortical cerebral infarction on cortical glucose metabolism and cognitive function. ArchNeurology 1999;56:809-14.

8. Rango M, Spagnoli D, Tomei G, Bamonti F, Scarlato G, Zetta L. Central Nervous

System Trans-Synaptic Effects of Acute Axonal Injury: A 1H Magnetic Resonance Spectroscopy Study. MRM ed: Williams & Wilkins; 1995.

9. Escobar A. Cerebral changes associated with senility. I. The role of transneuronal degeneration in the neocortex. Bol Estud Med Biol 1973;28(1):1-8.

10. Schuff N, Capizzano AA, Du AT, et al. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD. Neurology 2002;58(6):928-35.

11. Southwick SM, Paige S, Morgan CA, Bremner JD, Krystal JH, Charney DS.

Neurotransmitter alterations in PTSD: catecholamines and serotonin. Semin Clin Neuropsychiatry 1999;4(4):242-8.

12. Wang S, Mason J, Southwick S, Johnson D, Lubin H, Charney D. Relationships between thyroid hormones and symptoms in combat-related posttraumatic stress disorder. Psychosom Med 1995;57(4):398-402.

13. Yehuda R, Southwick SM, Krystal JH, Bremner D, Charney DS, Mason JW.

Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. AmJPsychiatry 1993;150(1):83-6.

14. Bremner JD, Randall P, Scott TM, et al. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry 1995;152:973-81.

15. Gurvits TV, Shenton ME, Hokama H, et al. Magnetic resonance imaging study of hippocampal volume in chronic, combat-related post-traumatic stress disorder. Biological Psychiatry 1996;40:1091-9.

16. Bremner JD, Randall P, Vermetten E, et al. MRI-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse-A preliminary report. Biological Psychiatry 1997;41:23-32.

17. Stein MB, Koverola C, Hanna C, Torchia MG, McClarty B. Hippocampal volume in women victimized by childhood sexual abuse. Psychol Med 1997;27(4):951-9.

18. Schuff N, Marmar CR, Weiss DS, et al. Reduced hippocampal volume and n-

acetylaspartate in post traumatic stress disorder. The Annals of the New York Academy of Sciences 1997; Supplement on Psychobiology of Posttraumatic Stress Disorder(821):516-20.

19. Freeman TW, Cardwell D, Karson CN, Komoroski RA. In vivo proton magnetic resonance spectroscopy of the medial temporal lobes of subjects with combat-related posttraumatic stress disorder. MagnResonMed 1998;40(1):66-71.

20. Schuff N, Amend D, Ezekiel F, et al. Changes of hippocampal n-acetylaspartate and volume in Alzheimer's disease: A proton MR spectroscopic imaging and MRI study. Neurology 1997;49:1513-21.

21. Kalra S, Cashman NR, Genge A, Arnold DL. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport 1998;9(8):1757-61.

22. Hugg JW, Kuzniecky RI, Gilliam FG, Morawetz RB, Faught RE, Hetherington HP.

Normalization of contralateral metabolic function following temporal lobectomy demonstrated by h-1 magnetic resonance spectroscopic imaging. Ann Neurol 1996;V40:236-9.

23. De Stefano N, Matthews PM, Arnold DL. Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995;34:721-7.

24. Bertolino A, Callicott JH, Mattay VS, et al. The effect of treatment with antipsychiatric drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biological Psychiatry 2001;49:39-46.

25. Heimberg C, Komoroski RA, Lawson WB, Cardwell D, Karson CN. Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect. Psychiatry Res 1998;83(2):105-15.

26. Meyerhoff DJ, Weiner MW, Fein G. Deep gray matter structures in HIV infection: a proton MR spectroscopic study. AJNR Am J Neuroradiol 1996;17(5):973-8.

27. Meyerhoff DJ, Cardenas V, Studholme C, et al. Evidence for Brain Damage in

Treated HIV-infected Individuals. Neurology 2003;60(5):A186.

28. Meyerhoff DJ, Truran D, Flenniken D, Song E, Studholme C, Weiner MW.

Longitudinal Multi-Slice Short-Te 1H MRSI Reveals On Going Brain Metabolite Injury In Treated HIV+ Patients And In Chronic Heavy Drinkers. Proc Intl Soc Mag Reson Med 2004;11:290.

29. Fein G, Meyerhoff DJ, Di Sclafani V, et al. 1H magnetic resonance spectroscopic imaging separates neuronal from glial changes in alcohol-related brain atrophy. Chapter in NIAAA Research Monograph No 27/Alcohol and Glial Cells 1994:227-41.

30. O'Neill J, Cardenas VA, Meyerhoff DJ. Separate and interactive effects of cocaine and alcohol dependence on brain structures and metabolites: quantitative MRI and proton MR spectroscopic imaging. Addiction Biology 2001;6:347-61.

31. O'Neill J, Cardenas VA, Meyerhoff DJ. Effects of abstinence on the brain:

quantitative magnetic resonance imaging and magnetic resonance spectroscopic imaging in chronic alcohol abuse. Alcohol Clin Exp Res 2001;25(11):1673-82.

32. Gazdzinski S, Durazzo TC, Meyerhoff D. Brain Recovery During Abstinence from

Alcohol: MRI, MR Spectroscopic Imaging, and Neurocognitive Studies. In: American Academy of Neurology 56th Annual Meeting; 2004; Moscone Convention Center, San Francisco, CA USA: American Academy of Neurology; 2004. p. A542.

33. Meyerhoff D, Blumenfeld R, Truran D, et al. Effects of heavy drinking, binge drinking, and family history of alcoholism on regional brain metabolites. Alcohol Clin Exp Res 2004;28(4):650-61.

34. , Bloomer CW, Langleben DD, Meyerhoff DJ. Magnetic resonance detects brainstem changes in chronic, active heavy drinkers. Psychiatry Res 2004; 132(3): 209-18

35. Duc O, Trabesinger AH, Weber OM, et al. Quanititative 1HMRS in the evaluation of mesial temporal lobe epilepsy in vivo. Magn Reson Imaging 1998;16:969-79.

36. Suhy J, Laxer KD, Capizzano AA, et al. 1H MRSI predicts surgical outcome in

MRI-negative temporal lobe epilepsy. Neurology 2002;58(5):821-3.

37. Mueller S, Laxer K, Barakos J, et al. Focus identification in neocortical epilepsy with

MR-spectroscopic imaging. Submitted.

38. Mueller S, Laxer K, Barakos J, et al. Metabolic characteristics causing epilepsy.


39. Ende GR, Laxer KD, Knowlton RC, et al. Temporal lobe epilepsy: bilateral hippocampal metabolite changes revealed at proton MR spectroscopic imaging. Radiology 1997;202(3):809-17.

40. Cendes F, Andermann F, Dubeau F, Matthews PM, Arnold DL. Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy -Evidence from proton MR spectroscopic imaging. Neurology 1997;49:1525-33.

41. Mueller S, Laxer K, Cashdollar N, Flenniken D, Matson G, Weiner M. Identification of Abnormal Neuronal Metabolism Outside the Seizure Focus in Temporal Lobe Epilepsy. Epilepsia 2004;45(4):355-66.

42. Mueller S, Suhy J, Laxer K, et al. Reduced extrahippocampal NAA in mesial temporal lobe epilepsy. Epilepsia 2002;43:1210-6.

43. Pioro EP, Antel JP, Cashman NR, Arnold DL. Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology 1994;44(10):1933-8.

44. Jones AP, Gunawardena WJ, Coutinho CM, Gatt JA, Shaw IC, Mitchell JD.

Preliminary results of proton magnetic resonance spectroscopy in motor neurone disease (amytrophic lateral sclerosis). J Neurol Sci 1995;129 Suppl:85-9.

45. Gredal O, Rosenbaum S, Topp S, Karlsborg M, Strange P, Werdelin L.

Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy [see comments]. Brain 1997;48(4):878-81.

46. Giroud M, Walker P, Bernard D, et al. Reduced brain N-acetyl-aspartate in frontal lobes suggests neuronal loss in patients with amyotrophic lateral sclerosis [published erratum appears in Neurol Res 1997 Aug;19(4):456]. NeurolRes 1996;18(3):241-3.

47. Cwik VA, Hanstock CC, Allen PS, Martin WR. Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy. Neurology 1998;50(1):72-7.

48. Ellis CM, Simmons A, Andrews C, Dawson JM, Williams SC, Leigh PN. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings. Neurology 1998;51(4):1104-9.

49. Block W, Karitzky J, Treaber F, et al. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements [see comments]. Arch Neurol 1998;55(7):931-6.

50. Pioro EP, Majors AW, Mitsumoto H, Nelson DR, Ng TC. 1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla. Neurology 1999;53(1):71-9.

51. Bradley WG, Bowen BC, Pattany PM, Rotta F. 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. J Neurol Sci 1999;169(1-2):84-6.

52. Bowen BC, Pattany PM, Bradley WG, et al. MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. Am J Neuroradiol 2000;21(4):647-58.

53. Chan S, Shungu DC, Douglas-Akinwande A, Lange DJ, Rowland LP. Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain. 1999;212(3):763-9.

54. Tarducci R, Sarchielli P, Presciutti O, et al. Study of the primary motor cortex in amyotrophic lateral sclerosis by quantitative 1HMRS. ISMRM 2000;1:632.

55. Petropoulos H, Mandler RN, Qualls C, et al. 1H-MRS reveals diffuse neuronal injury in Amyotrophic Lateral Sclerosis. ISMRM 2000;1:633.

56. Kalra S, Arnold DL, Cashman NR. Biological markers in the diagnosis and treatment of ALS. J Neurol Sci 1999;165 Suppl 1:S27-S32.

57. Rooney WD, Miller RG, Gelinas D, Schuff N, Maudsley AA, Weiner MW.

Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Neurology 1998;50(6):1800-5.

58. Schuff N, Rooney WD, Miller RG, et al. Reanalysis of Multislice 1H MRSI in

Amyotrophic Lateral Sclerosis. Magnetic Resonanc in Medicine 2001;45:513-6.


Kent Harris, Alexander Lin, Pratip Bhattacharya, Thao Tran, Willis Wong and Brian Ross*

Unraveling Alzheimers Disease

Unraveling Alzheimers Disease

I leave absolutely nothing out! Everything that I learned about Alzheimer’s I share with you. This is the most comprehensive report on Alzheimer’s you will ever read. No stone is left unturned in this comprehensive report.

Get My Free Ebook

Post a comment